Listen and follow our podcasts on:

This educational programme is supported by an Independent Educational Grant from Eisai Europe

Listen to the podcast

 

In this educational podcast, Veerle Lamotte and Paola Belardi share their successful experience of managing patients treated with VEGFR-TKIs for select solid tumours.

The short 15-minute discussion captures and provides you with their useful insight on:

1. The safety profile of VEGFR-TKIs alone or in combination with PD-1 inhibitors in hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) & advanced renal cell carcinoma (RCC) and how to recognise side effects & understand appropriate management

2. How to best manage patients both prior to & during treatment to ensure optimal treatment success, including prehabilitation of patients prior to treatment & management of side effects on treatment

Veerle and Paola have many years nursing experience and present views not only from the perspective of the nurse, but also with relevance across geographies.

This is the first collaboration between GI NURSES CONNECT and GU NURSES CONNECT on an educational programme offering a valuable resource that is not limited to one tumour type.

This GI NURSES CONNECT and GU NURSES CONNECT podcast is also available on
Castos, Spotify, Apple Podcasts, and Google Podcasts.

Veerle Lamotte has worked as an oncology nurse practitioner at Antwerp University Hospital since 2013. She graduated as a nurse in 2001, working initially in intensive care before moving to work in oncology in 2010. Veerle supports and guides patients within the tumour cluster uro-oncology care process; from diagnosis, during treatment, follow-up phase and at relapse.  As an oncology nurse she has detailed knowledge and experience of urology, oncology and palliative care. Veerle is also a board member of UROBEL (the Belgian National Association for Urological Nurses) which keep nurses in Belgium informed about new strategies in uro-oncological healthcare. 

Veerle Lamotte has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Ipsen and Pfizer. 

Paola Belardi is a Nurse Co-ordinator at San Donato Hospital in Arezzo, Italy. Paola gained her first level Nursing Degree at the University of Siena in 2000. Later, in 2002 she attended a Public Health class at the University of Florence and in 2010 she graduated the Master Degree in Management at the University of Siena. In 2013 she started her work in oncology setting and now she is principally committed in activities such as nurse staffing and quality standard in oncology. From 2018 she is also an adjunct professor teaching Oncology Nursing at the University of Siena. Her professional interests are: chemotherapy and target therapy side effects management, intravenous devices management and nurses education. In the last month she has been co-supervisor of two Nursing Degree thesis: one studying the nurses’ role in fatigue prevention and the other regarding the nurses’ level of knowledge about simultaneous care model.

Programme summary
  • clock Duration 15 MIN
  • clock Language(s) flag
Listen to the podcast now
Share this programme
This educational programme is supported by an Independent Educational Grant from Eisai Europe
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU NURSES CONNECT

GU NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer, and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

video Video
Oncology 
Recent advances in precision oncology and future implications

Two emerging and two established targets

Experts
Prof. David Hong
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Survey on the evolving role of the oncology nurse in the USA

Announcing the publication of survey results 

Experts
Nina Grenon, Natasha Pinheiro, Karen Waldrop, Brittni Prosdocimo
  • download Downloadable
    Resources
  • clock 10 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Bayer.
video Video
Oncology 
Elacestrant in ER+/HER2- metastatic breast cancer

An expert overview of the EMERALD subgroup analysis

Experts
Dr Virginia Kaklamani
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
video Video
Oncology 
Systemic treatment options for patients with non-clear cell renal cell carcinoma (nccRCC)

Managing patients with nccRCC: guidelines, recommendations, and best practice

Experts
Prof. Laurence Albiges
Endorsed by
Urobel VZW | ASBL
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Eisai Europe Limited (“Eisai”). Eisai has had no input on the educational content of, or speakers involved in this programme. 
micro-learning Micro learning
Oncology 
Metastatic pancreatic ductal adenocarcinoma (PDAC): from diagnosis to treatment

Risk factors, diagnostic tools and treatment options for different patient groups

Experts
Prof. Efrat Dotan, Prof. Shubham Pant
Endorsed by
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Ipsen USA.
conference-update Conference update
Oncology 
Rezatapopt in TP53 Y220C mutated metastatic breast cancer: PYNNACLE phase 1/2 update

Exploring emerging treatment strategies presented at SABCS 2024

Experts
Prof. Frédérique Penault-Llorca, Dr Ecaterina E Dumbrava
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Dec 2024

This programme has been sponsored by PMV Pharma.